Cancer du col de l'utérus : première résolution 3D d’une oncoprotéine du virus à papillome humain

These contents could be interesting :

A new class of molecules against cancer cells refractory to standard treatments

A new class of molecules capable of killing the cancer cells that are refractory to standard treatments and responsible for recurrence has just been developed by scientists at Institut....

A new antibody-drug conjugate shows promising results in metastatic breast cancer

A new study, published in Nature Medicine, highlights the efficacy of patritumab deruxtecan (HER3-DXd), an antibody HER3-directed-drug conjugate (ADC), in patients with hormone receptor-positive metastatic breast cancer who had....

Medias

Researcher Contact

Gilles Travé l T 06 52 47 60 52/03 68 85 47 20 l rf.artsinu@evart.selligKatia Zanier l T 03 68 85 44 06 l rf.artsinu@reinaz

Sources

Structural basis for hijacking of cellular LxxLL motifs by papillomavirus E6 oncoproteins.Zanier K, Charbonnier S, Ould M'hamed Ould Sidi A, Mc Ewen AG, Ferrarrio MG, Poussin P., Cura V, Brimer N, Ould Babah K, Ansari T, Muller I, Stote RH, Cavarelli J, Vande Pol S, Travé G. Science, 8 February 2013, Vol. 339 no. 6120 pp. 694-698

Inserm Newsroom - Press room of the French national institute of health and medical research

Cancer du col de l’utérus : première résolution 3D d’une oncoprotéine du virus à papillome humain

These contents could be interesting :

A new class of molecules against cancer cells refractory to standard treatments

A new antibody-drug conjugate shows promising results in metastatic breast cancer

Researcher Contact